FindTrial
Sign In

Evaluation of the efficacy and safety of endoscopic submucosal dissection (ESD) and surgical treatment for gastric signet ring cell carcinoma: A retrospective single-center study

Evaluation of the efficacy and safety of endoscopic submucosal dissection (ESD) and surgical treatment for gastric signet ring cell carcinoma: A retrospective single-center study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111745
Enrollment
Unknown
Registered
2025-11-05
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric signet-ring cell carcinoma

Interventions

ESD treatment group:None
Surgical treatment group:None

Sponsors

Affiliated Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From December 2004 to December 2024, patients with gastric SRCC who underwent ESD or surgical treatment at Beijing Friendship Hospital.

Exclusion criteria

Exclusion criteria: There are patients who have ESD or surgical contraindications, or who are unable to complete the procedure or give informed consent.

Design outcomes

Primary

MeasureTime frame
Red blood cell count;White blood cell count;Hemoglobin;C-reactive protein;Procalcitonin;Liver function;Renal function;Pathological results;The situation of the second intervention;Hospitalization period;Re-admission situation;—

Countries

China

Contacts

Public ContactLi Peng

Affiliated Beijing Friendship Hospital, Capital Medical University

lipeng@ccmu.edu.cn+86 135 2113 6454

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026